Browse > Article

Nerve Growth Factor and Sensory Neuropeptide Levels in Plasma and Saliva of Various Orofacial Pain Patients  

Jang, Min-Uk (Department of Oral Medicine and Oral Diagnosis School of Dentistry and Dental Research Institute, Seoul National University)
Chung, Sung-Chang (Department of Oral Medicine and Oral Diagnosis School of Dentistry and Dental Research Institute, Seoul National University)
Chung, Jin-Woo (Department of Oral Medicine and Oral Diagnosis School of Dentistry and Dental Research Institute, Seoul National University)
Publication Information
Journal of Oral Medicine and Pain / v.34, no.4, 2009 , pp. 387-395 More about this Journal
Abstract
Nerve growth factor (NGF) and sensory neuropeptides are involved in the process of nociception at peripheral nerve fibers and wide spread in central nervous system. The aims of this study were to investigate NGF and sensory neuropeptides (substance P [SP] and calcitonin gene-related peptide [CGRP]) levels in human plasma and saliva, and the associations between these sensory neuropeptides levels and chronic orofacial pain symptoms. NGF, SP, and CGRP levels in plasma and resting whole saliva samples collected from 67 orofacial pain patients (joint pain, dental or periodontal pain, mucosal pain) and 36 pain free control subjects were measured by enzyme immunoassay. The characteristic pain intensity of each subject was measured using the Graded Chronic Pain Scale and the flow rate of resting whole saliva was measured. Joint pain patients group showed significantly higher plasma NGF level compared to each of dental pain patients (p<0.01), mucosal pain patients (p<0.01), and control group (p<0.01). Plasma NGF level of dental pain patients group was significantly higher than that of control group (p<0.01). Saliva SP level of dental pain patients group (p<0.05) and saliva CGRP level of mucosal pain group (p<0.05) were significantly higher than that of control group. Plasma and saliva SP levels of joint pain patients was significantly associated with pain intensity (plasma: standardized coefficient=0.599, p<0.01, saliva: standardized coefficient=0.504, p=0.05). In dental pain patients group, plasma SP (standardized coefficient=0.559, p<0.01), saliva SP (standardized coefficient=0.520, p<0.01) and saliva CGRP (standardized coefficient=0.599, p<0.01) levels were significantly associated with age. In mucosal pain patients group, plasma SP (standardized coefficient=0.495, p<0.05), saliva SP (standardized coefficient=0.500, p<0.05), and saliva CGRP (standardized coefficient=0.717, p<0.01) levels were significantly associated with age. NGF and neuropeptides may play a role in the maintenance of various orofacial pain symptoms. The examination of those levels in plasma and saliva helps understanding the mechanism of orofacial pain, and furthermore, can be applied to the diagnosis and therapy of orofacial pain.
Keywords
Plasma; Saliva; Nerve growth factor; Substance P; Calcitonin gene-related peptide;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994 Nov;37(11):1593-601   DOI   ScienceOn
2 Dicou E, Perrot S, Menkes CJ, Masson C, Nerriere V. Nerve growth factor(NGF) autoantibodies and NGF in the synovial fluid: implications in spondylarthropathies. Autoimmunity 1996 24(1):1-9   DOI   ScienceOn
3 Pelegrini-da-Silva A, Oliviera MCG, Parada CA, Tambeli CH. Nerve growth factor acts with the 2-adrenoceptor to induce spontaneous nociceptive behavior during tempromandibular joint inflammatory hyperalgesia. Life Science 2008;83:780-785   DOI
4 Woolf CJ, Safieh-Garabedian B, Ma Q-P, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994;62(2);327-331   DOI   ScienceOn
5 Marukawa H, Shimomura T, Tahahashi K. Salivary substance P, 5- ydroxytryptamin, and gammaaminobutyric acid levels in migraine and tension-type headache. Headache 1996 Frb;36(2):100-104   DOI   ScienceOn
6 Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50:133-49   DOI   ScienceOn
7 Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124(10):115-21
8 Cirulli F. Role of environmental factors on brain development and nerve growth factor expression. Physiol Behav. 2001 Jun;73:321-330. Review   DOI   ScienceOn
9 Paola S, Andrea A, Ardesio F, Virgilio G. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 2001;57:132-134   DOI   ScienceOn
10 Khasabov SG, Rogers SD, Ghilardi JR, Peters CM, Mantyh PW, Simone DA. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 2002;22(20):9086-9098
11 Kolzenburg M, Bennett DL, Shelton DL. Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin. Eur J Neurosci 1999;11:1698-1704   DOI   ScienceOn
12 Hadjiconstantinou M, McGuire L, Duchemin AM, Laskowski B, Kiecolt-Glaser J, Glaser R. Changes in plasma nerve growth factor levels in older adults associated with chronic stress. J Neuroimmunol 2001 May1;116(1):102-106   DOI   ScienceOn
13 Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin-gene related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992;49:693-698   DOI   ScienceOn
14 Shu X-Q, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA 1999;96:7693-7696   DOI   ScienceOn
15 Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis and Rheumatism 1992;35(3):351-355   DOI   ScienceOn
16 Nicolodi M, Del Bianco E. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva:their pattern in migraine and cluster headache. Cephalalgia 1990;10;39-50   DOI   ScienceOn